Schwarzenegger backs stem cell plan
By Associated Press,
Associated Press
| 10. 19. 2004
SAN FRANCISCO, California (AP) -- Gov. Arnold Schwarzenegger has endorsed a $3 billion bond measure that would fund human embryonic stem cell research, a move that bucks Republican leaders and threatens to further strain the state's budget.
"California has always been a pioneer," Schwarzenegger said Monday. "We daringly led the way for the high-tech industry and now voters can help ensure we lead the way for the biotech industry."
The endorsement of the stem cell research measure comes at some political risk for the governor, who campaigned against California going deeper into debt when he unseated Gray Davis as governor in last year's recall election.
The endorsement also will put Schwarzenegger at odds with the state Republican Party, which officially opposes Proposition 71, and perhaps the Bush administration, which has limited federal funding of the research.
"It's a surprise given the economic challenges facing the state," said Jack Pitney, a political scientist at Claremont McKenna College who is voting against the measure.
"Social conservatives might be unhappy, too, but he was never their favorite anyway."
Schwarzenegger has said he supports...
Related Articles
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...
By Roni Caryn Rabin, The New York Times | 01.22.2026
The National Institutes of Health said on Thursday it is ending support for all research that makes use of human fetal tissue, eliminating funding for projects both within and outside of the agency.
A ban instituted in June 2019 by...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...